Although treatments can often seem standard and straightforward, the more we know about the patient, the better our chance of helping them to achieve successful outcomes.
In January, the U.S. FDA said a preliminary review showed no evidence of such a link, though the agency said it could not rule out that ‘a small risk may exist.’
The Ontario College of Pharmacists has announced it will take steps to address preferred provider networks—including exploring stronger regulatory responses.
